A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)
This is a Phase III, randomized, open-label, active-controlled study to evaluate the safety and efficacy of AND017 in non-dialysis-dependent (NDD)-CKD patients compared with the active control, ESA treatment
A diagnosis of CKD confirmed at screening, KDOQI CKD stage 3, 4, or 5 defined by... [+7]
Concurrent retinal neovascular lesions requiring treatment. [+10]